Development of 3D wet-spun polymeric scaffolds loaded with antimicrobial agents for bone engineering

Three-dimensional wet-spun microfibrous meshes of a star poly(∈-caprolactone) were developed as potential scaffolds endowed with antimicrobial activity. The in vitro release kinetics of the meshes, under physiological conditions, was initially fast and then a sustained release for more than one month was observed. Cell cultures of a murine pre-osteoblast cell line showed good cell viability and adhesion on the wet-spun star poly(∈-caprolactone) fiber scaffolds. These promising results indicate a potential application of the developed meshes as engineered bone scaffolds with antimicrobial activity.

[1]  R. Reis,et al.  Optimized electro‐ and wet‐spinning techniques for the production of polymeric fibrous scaffolds loaded with bisphosphonate and hydroxyapatite , 2011, Journal of tissue engineering and regenerative medicine.

[2]  V. Guarino,et al.  hMSC interaction with PCL and PCL/gelatin platforms: A comparative study on films and electrospun membranes , 2011 .

[3]  D. Paneva,et al.  Drug-loaded electrospun polylactide bundles , 2011 .

[4]  Federica Chiellini,et al.  Poly(vinyl alcohol)-based electrospun meshes as potential candidate scaffolds in regenerative medicine , 2011 .

[5]  Kerm Sin Chian,et al.  Fabrication and in vitro and in vivo cell infiltration study of a bilayered cryogenic electrospun poly(D,L-lactide) scaffold. , 2010, Journal of biomedical materials research. Part A.

[6]  Federica Chiellini,et al.  Development of electrospun three-arm star poly(ε-caprolactone) meshes for tissue engineering applications. , 2010, Macromolecular bioscience.

[7]  Claudio Migliaresi,et al.  Electrodeposition of Silk Fibroin on Metal Substrates , 2010 .

[8]  Federica Chiellini,et al.  Poly(lactic-co-glycolic acid) electrospun fibrous meshes for the controlled release of retinoic acid. , 2010, Acta biomaterialia.

[9]  Federica Chiellini,et al.  Polymeric Materials for Bone and Cartilage Repair , 2010 .

[10]  F. Yılmaz,et al.  Synthesis, characterization and thermal properties of a novel star polymer consisting of poly(ε-caprolactone) arms emanating from an octa-functional porphyrazine core , 2009 .

[11]  Katja Schenke-Layland,et al.  Three-dimensional electrospun ECM-based hybrid scaffolds for cardiovascular tissue engineering. , 2008, Biomaterials.

[12]  M. S. San Andres,et al.  Pharmacokinetic behaviour of enrofloxacin and its metabolite ciprofloxacin after subcutaneous administration in cattle , 2008, Veterinary Research Communications.

[13]  K. Lee,et al.  Preparation and characterization of wet spun silk fibroin/poly(vinyl alcohol) blend filaments. , 2007, International journal of biological macromolecules.

[14]  Yueqing Gu,et al.  The implantable 5-fluorouracil-loaded poly(l-lactic acid) fibers prepared by wet-spinning from suspension. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[15]  Qing Yang,et al.  In vitro degradation and biocompatibility of poly(l-lactic acid)/chitosan fiber composites , 2007 .

[16]  R. L. Reis,et al.  A cartilage tissue engineering approach combining starch-polycaprolactone fibre mesh scaffolds with bovine articular chondrocytes , 2007, Journal of materials science. Materials in medicine.

[17]  K. Nelson,et al.  Release of bovine serum albumin from a hydrogel‐cored biodegradable polymer fiber , 2006, Biopolymers.

[18]  P. Dubois,et al.  Three‐arm poly (ε‐caprolactone) by extrusion polymerization , 2006 .

[19]  Antonios G Mikos,et al.  In vitro localization of bone growth factors in constructs of biodegradable scaffolds seeded with marrow stromal cells and cultured in a flow perfusion bioreactor. , 2006, Tissue engineering.

[20]  P. Törmälä,et al.  In vitro and in vivo release of ciprofloxacin from osteoconductive bone defect filler. , 2005, The Journal of antimicrobial chemotherapy.

[21]  G. Smith,et al.  Evaluation of in vitro drug release, pH change, and molecular weight degradation of poly(L-lactic acid) and poly(D,L-lactide-co-glycolide) fibers. , 2005, Tissue engineering.

[22]  M. McKee,et al.  Branched polyesters: recent advances in synthesis and performance , 2005 .

[23]  J. Knuuti,et al.  Efficacy of Ciprofloxacin-Releasing Bioabsorbable Osteoconductive Bone Defect Filler for Treatment of Experimental Osteomyelitis Due to Staphylococcus aureus , 2005, Antimicrobial Agents and Chemotherapy.

[24]  Seeram Ramakrishna,et al.  Electrospinning of gelatin fibers and gelatin/PCL composite fibrous scaffolds. , 2005, Journal of biomedical materials research. Part B, Applied biomaterials.

[25]  J. Calhoun,et al.  Osteomyelitis in long bones. , 2004, The Journal of bone and joint surgery. American volume.

[26]  C. M. Alves,et al.  Production and characterization of chitosan fibers and 3-D fiber mesh scaffolds for tissue engineering applications. , 2004, Macromolecular bioscience.

[27]  P. Dubois,et al.  Kinetic and thermodynamic considerations in the synthesis of a new three‐arm poly(ε‐caprolactone) , 2004 .

[28]  K. Oungbho,et al.  The efficacy of a hydroxyapatite composite as a biodegradable antibiotic delivery system. , 2004, Clinical orthopaedics and related research.

[29]  A. MacGowan,et al.  Antibiotic treatment of gram-positive bone and joint infections. , 2004, The Journal of antimicrobial chemotherapy.

[30]  Y. H. Park,et al.  Wet spinning of silk polymer. II. Effect of drawing on the structural characteristics and properties of filament. , 2004, International journal of biological macromolecules.

[31]  John M. Wright,et al.  Effective Treatment of Osteomyelitis with Biodegradable Microspheres in a Rabbit Model , 2004, Clinical orthopaedics and related research.

[32]  Timothy E. Long,et al.  Correlations of solution rheology with electrospun fiber formation of linear and branched polyesters , 2004 .

[33]  A. Coombes,et al.  Gravity spinning of polycaprolactone fibres for applications in tissue engineering. , 2004, Biomaterials.

[34]  A Delgado,et al.  Ciprofloxacin implants for bone infection. In vitro-in vivo characterization. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[35]  Antonios G Mikos,et al.  Effect of flow perfusion on the osteogenic differentiation of bone marrow stromal cells cultured on starch-based three-dimensional scaffolds. , 2003, Journal of biomedical materials research. Part A.

[36]  Robin Patel,et al.  Levofloxacin and Trovafloxacin Inhibition of Experimental Fracture-Healing , 2003, Clinical orthopaedics and related research.

[37]  A. Delgado,et al.  In vitro-in vivo characterization of gentamicin bone implants. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[38]  E. Rubinstein.  History of Quinolones and Their Side Effects , 2001, Chemotherapy.

[39]  X Huang,et al.  On the importance and mechanisms of burst release in matrix-controlled drug delivery systems. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[40]  D. Bjorling,et al.  In vitro antibacterial activity of enrofloxacin and ciprofloxacin in combination against Escherichia coli and staphylococcal clinical isolates from dogs. , 2001, Research in veterinary science.

[41]  B. Frenkel,et al.  Inhibitory effects of the quinolone antibiotics trovafloxacin, ciprofloxacin, and levofloxacin on osteoblastic cells in vitro , 2000, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[42]  E. Denkbaş,et al.  Implantable 5-fluorouracil loaded chitosan scaffolds prepared by wet spinning , 2000 .

[43]  M E Bolander,et al.  Ciprofloxacin Inhibition of Experimental Fracture-Healing* , 2000, The Journal of bone and joint surgery. American volume.

[44]  R. Greenberg,et al.  Ciprofloxacin, Lomefloxacin, or Levofloxacin as Treatment for Chronic Osteomyelitis , 2000, Antimicrobial Agents and Chemotherapy.

[45]  Jeong-Hoon Kim,et al.  Effect of PEG additive on membrane formation by phase inversion , 1998 .

[46]  B. F. Barton,et al.  Observations on the dynamics of nonsolvent‐induced phase inversion , 1997 .

[47]  R. Boom,et al.  Recent advances in the formation of phase inversion membranes made from amorphous or semi-crystalline polymers , 1996 .

[48]  J. McClure,et al.  Pharmacokinetics of enrofloxacin in clinically normal dogs and mice and drug pharmacodynamics in neutropenic mice with Escherichia coli and staphylococcal infections. , 1995, American journal of veterinary research.

[49]  C. Tsay,et al.  A rationale for structure formation during phase inversion , 1992 .

[50]  C. Tsay,et al.  Mass transfer modeling of asymmetric membrane formation by phase inversion , 1990 .

[51]  C. A. Smolders,et al.  Formation of membranes by means of immersion precipitation : Part II. the mechanism of formation of membranes prepared from the system cellulose acetate-acetone-water , 1987 .

[52]  Richard W. Baker,et al.  The formation mechanism of asymmetric membranes , 1975 .

[53]  G H van Lenthe,et al.  A new route to produce starch-based fiber mesh scaffolds by wet spinning and subsequent surface modification as a way to improve cell attachment and proliferation. , 2010, Journal of biomedical materials research. Part A.

[54]  R. Reis,et al.  13 – Chitosan-based scaffolds in orthopaedic applications , 2008 .

[55]  A. Coombes,et al.  Controlled release of an antibiotic, gentamicin sulphate, from gravity spun polycaprolactone fibers. , 2008, Journal of biomedical materials research. Part A.

[56]  D. Hooper,et al.  Mechanisms of Quinolone Action , 2003 .

[57]  K. Goa,et al.  Levofloxacin: a review of its use in the treatment of bacterial infections in the United States. , 2003, Drugs.

[58]  Juming Yao,et al.  Artificial Spinning and Characterization of Silk Fiber from Bombyx mori Silk Fibroin in Hexafluoroacetone Hydrate , 2002 .

[59]  U A Stock,et al.  Tissue engineering: current state and prospects. , 2001, Annual review of medicine.

[60]  W. Burchard.  Solution Properties of Branched Macromolecules , 1999 .